With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage
Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.
The company plans to aggressively invest in longer gestation period projects like innovation, biosimilars, vaccines, etc.
The rating withdrawal is based on the company’s request and in line with CRISIL Rating’s policy on withdrawal of ratings.
The progress has been encouraging with approvals and launches in the US, EU, Japan, Australia and Emerging Markets. Post Mylan Upjohn (Pfizer) merger, the scope has been extended to China as well.
TCPCL is the largest and only commercial manufacturer of SDAs for zeolites in India
Vivimed strategy is to increase its share of Branded products in CIS Markets.
Penicillamine Tablets USP, 250 mg (RLD: Depen) had estimated annual sales of USD 5 million in the U.S. (IQVIA MAT December 2020).
Merck forecasts organic growth of EBITDA pre in a high single-digit to low teens percentage range in 2021.
Jubilant announced the completion of demerger of pharma and LSI business into two separate companies
Subscribe To Our Newsletter & Stay Updated
